Keywords: Biology, Models, Methods, Metabolism, Melanoma; Immunotherapy; 1H/31P magnetic resonance spectroscopy; oxygen consumption rate; extracellular acidification rate, Metabolic Modulation.
Motivation: Studying immunotherapy effects at the subcellular level in melanoma may reveal critical biomarkers of response and improve therapeutic strategies.
Goal(s): We aim to study the impact of anti-PD-1 immunotherapy on metabolite levels, bioenergetics, pH, diffusivity, and T2 relaxation times in immunogenic melanoma models.
Approach: We used in vivo MRI and MRS to assess the impact of anti-PD-1 immunotherapy on the immunogenic melanoma model YUMMER1.7.
Results: Early-phase changes in lactate, alanine, pH, bioenergetics, ADC, and T2 relaxation time occurred during anti-PD-1 immunotherapy. Preliminary in vitro studies with two metabolic modulators further characterized the metabolic phenotypes of isolated YUMMER1.7 melanoma cells.
Impact: This study emphasizes the potential of early subcellular changes (metabolism, pH, bioenergetics, diffusion, T2 relaxation) as predictive biomarkers of melanoma immunotherapy response. Preliminary findings with metabolic modulators indicate possible strategies for enhancing treatment outcomes through metabolic modulation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords